Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $3,901 | 9 | 52.7% |
| Food and Beverage | $3,491 | 47 | 47.1% |
| Education | $17.19 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Laboratories Inc | $2,471 | 8 | $0 (2018) |
| Regeneron Pharmaceuticals, Inc. | $2,421 | 7 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $550.93 | 11 | $0 (2024) |
| Alcon Vision LLC | $520.37 | 4 | $0 (2024) |
| Genentech USA, Inc. | $472.00 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $256.25 | 3 | $0 (2019) |
| Alimera Sciences, Inc. | $212.36 | 2 | $0 (2019) |
| Dutch Ophthalmic, USA | $140.42 | 1 | $0 (2024) |
| Allergan Inc. | $125.06 | 1 | $0 (2018) |
| Apellis Pharmaceuticals, Inc. | $70.19 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $946.59 | 18 | Genentech USA, Inc. ($390.62) |
| 2023 | $101.79 | 4 | Genentech USA, Inc. ($44.03) |
| 2022 | $23.43 | 1 | Genentech USA, Inc. ($23.43) |
| 2021 | $265.77 | 6 | Regeneron Healthcare Solutions, Inc. ($254.53) |
| 2020 | $173.74 | 3 | Alcon Vision LLC ($140.57) |
| 2019 | $2,292 | 11 | Regeneron Pharmaceuticals, Inc. ($1,733) |
| 2018 | $2,800 | 9 | Alcon Laboratories Inc ($1,879) |
| 2017 | $806.96 | 5 | Alcon Laboratories Inc ($591.53) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Dutch Ophthalmic, USA | EVA, combined machine (Device), TISSUEBLUE | Food and Beverage | In-kind items and services | $140.42 | General |
| Category: Ophthalmology | ||||||
| 10/29/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Ophthalmology | ||||||
| 10/14/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/30/2024 | Genentech USA, Inc. | Susvimo (Drug) | Food and Beverage | In-kind items and services | $30.56 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/17/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/16/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug), VISUDYNE, RETISERT | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Ophthalmology | ||||||
| 08/15/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/13/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/31/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Ophthalmology | ||||||
| 06/27/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $146.18 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/28/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $115.60 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/03/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $105.44 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/26/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $32.73 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/21/2024 | Biogen, Inc. | BYOOVIZ (Biological) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Ophthalmology | ||||||
| 04/17/2024 | Biogen, Inc. | BYOOVIZ (Biological) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Ophthalmology | ||||||
| 04/16/2024 | Alcon Vision LLC | NGENUITY (Device) | Food and Beverage | In-kind items and services | $136.14 | General |
| Category: Ophthalmology | ||||||
| 03/02/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $30.67 | General |
| Category: Immunology and Ophthalmology | ||||||
| 01/11/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Education | In-kind items and services | $17.19 | General |
| Category: Ophthalmology | ||||||
| 11/18/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/28/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/13/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $29.05 | General |
| Category: Ophthalmology | ||||||
| 01/19/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/01/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/18/2021 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $76.53 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/15/2021 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 2,860 | 20,850 | $6.2M | $2.0M |
| 2022 | 14 | 2,341 | 8,406 | $6.1M | $2.0M |
| 2021 | 15 | 2,212 | 7,970 | $4.8M | $1.5M |
| 2020 | 15 | 1,817 | 6,183 | $3.3M | $986,136 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 173 | 1,848 | $3.6M | $1.3M | 35.2% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 67 | 12,240 | $792,000 | $353,342 | 44.6% |
| 67028 | Injection of drug into eye | Office | 2023 | 346 | 1,571 | $709,844 | $134,577 | 19.0% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 677 | 1,346 | $331,992 | $110,928 | 33.4% |
| 92134 | Imaging of retina | Office | 2023 | 784 | 2,342 | $435,280 | $59,852 | 13.8% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 181 | 628 | $78,588 | $34,849 | 44.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 229 | 365 | $62,929 | $21,606 | 34.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 170 | 170 | $50,876 | $16,154 | 31.8% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 12 | 12 | $60,000 | $10,444 | 17.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 96 | $19,041 | $8,343 | 43.8% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 34 | 41 | $50,500 | $6,426 | 12.7% |
| J3590 | Unclassified biologics | Office | 2023 | 42 | 121 | $15,246 | $5,464 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $8,395 | $2,909 | 34.7% |
| 76510 | 1d and 2d ultrasound scan of eye tissue and structures | Office | 2023 | 18 | 19 | $5,700 | $974.70 | 17.1% |
| 92250 | Photography of the retina | Office | 2023 | 11 | 12 | $1,560 | $318.91 | 20.4% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 11 | 13 | $650.00 | $222.00 | 34.2% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 151 | 2,260 | $4.5M | $1.6M | 36.3% |
| 67028 | Injection of drug into eye | Office | 2022 | 285 | 1,497 | $690,792 | $130,171 | 18.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 569 | 1,118 | $275,524 | $91,844 | 33.3% |
| 92134 | Imaging of retina | Office | 2022 | 665 | 2,159 | $406,500 | $55,594 | 13.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 241 | 444 | $77,128 | $25,965 | 33.7% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 145 | 477 | $59,694 | $25,729 | 43.1% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 149 | 149 | $44,607 | $14,052 | 31.5% |
| J3590 | Unclassified biologics | Office | 2022 | 50 | 203 | $25,578 | $9,388 | 36.7% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2022 | 13 | 13 | $15,750 | $2,132 | 13.5% |
About Dr. Lauren Wright, M.D
Dr. Lauren Wright, M.D is a Retina Specialist healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2013. The National Provider Identifier (NPI) number assigned to this provider is 1992142350.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lauren Wright, M.D has received a total of $7,409 in payments from pharmaceutical and medical device companies, with $946.59 received in 2024. These payments were reported across 57 transactions from 15 companies. The most common payment nature is "Travel and Lodging" ($3,901).
As a Medicare-enrolled provider, Wright has provided services to 9,230 Medicare beneficiaries, totaling 43,409 services with total Medicare billing of $6.5M. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Retina Specialist
- Location Nashville, TN
- Active Since 05/25/2013
- Last Updated 05/12/2025
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1992142350
Products in Payments
- DAILIES (Device) $936.89
- Vabysmo (Drug) $404.09
- EYLEA (Biological) $400.69
- Constellation (Device) $250.80
- EYLEA HD (Biological) $150.24
- EVA, combined machine (Device) $140.42
- NGENUITY (Device) $136.14
- OZURDEX (Drug) $125.06
- ORA (Device) $124.99
- Iluvien (Drug) $121.92
- Centurion (Device) $120.49
- Iluvien (Biological) $90.44
- Syfovre (Drug) $70.19
- Spectralis (Device) $68.13
- BYOOVIZ (Biological) $46.64
- Susvimo (Drug) $30.56
- Izervay (Drug) $23.79
- BEOVU (Drug) $23.48
- VABYSMO (Drug) $23.43
- XIPERE (Drug) $20.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Retina Specialist Doctors in Nashville
Dr. Brandon Busbee, M.d, M.D
Retina Specialist — Payments: $581,981
Dr. Edward Chaum, Md Phd, MD PHD
Retina Specialist — Payments: $185,988
Hesham Gabr, Md, MD
Retina Specialist — Payments: $3,961
Bernard Dib, M.d, M.D
Retina Specialist — Payments: $3,171
Dr. Heikki Kostamaa, M.d, M.D
Retina Specialist — Payments: $876.94